Fitbone is designed to lengthen the femur and tibia bones. The acquisition also includes other potential applications of the technology that are in development, including FitSpine for fusion less surgery to treat scoliosis.
The system is implanted in the bone through a minimally invasive procedure. Treatment can be tracked through a Fitbone ap that guides the patient throughout the limb-lengthening treatment.
“The acquisition of Fitbone intramedullary lengthening system further demonstrates Orthofix’s commitment to investing in differentiated products that are a strong strategic fit within our core businesses,” president and CEO Jon Serbousek said in a news release. “Adding this technology to our current limb reconstruction portfolio enables us to offer physicians solutions to meet the needs of their patients which may require internal or external fixation procedures. We look forward to developing other applications of this exciting platform.”
The terms of the agreement with Wittenstein, who developed the Fitbone system, include $18 million in cash closing consideration and a manufacturing supply contract.
Orthofix plans to integrate the Fitbone system into its extremities portfolio.